Prosecution Insights
Prosecution Insights
Tech Center 1700 • Art Units: 1623 1673 1693 1773 1793
This examiner grants 64% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18570416 | PROCESS FOR PREPARING POLYSACCHARIDE SULFATES, AND POLYSACCHARIDE SULFATE | Non-Final OA | FRAUNHOFER-GESELLSCHAFT ZUR FÖRDERUNG DER ANGEWANDTEN FORSCHUNG E.V. |
| 18285789 | THIONUCLEOSIDES AS ANTIVIRAL AGENTS | Non-Final OA | Emory University |
| 18704516 | FINE CELLULOSE FIBER SOLID MATERIAL AND METHOD FOR PRODUCING FINE CELLULOSE FIBER SOLID MATERIAL | Non-Final OA | Yokogawa Electric Corporation |
| 18493223 | THERAPEUTIC POLY-ADP-RIBOSE POLYMER-GCSF CONJUGATES | Non-Final OA | UNIVERSITY OF SOUTHERN CALIFORNIA |
| 18573684 | METHODS FOR TREATING FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY (FSHD) | Non-Final OA | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL |
| 17799992 | PURIFICATION OF SACCHARIDES | Final Rejection | Pfizer Inc. |
| 18726524 | EXTERNAL-USE SKIN PREPARATION COMPOSITION | Non-Final OA | SHISEIDO COMPANY, LTD. |
| 18570695 | ORGANOPOLYSILOXANE-MODIFIED CYCLODEXTRIN COMPOUND, METHOD FOR PRODUCING SAME, AND COSMETIC CONTAINING SAME | Non-Final OA | SHIN-ETSU CHEMICAL CO., LTD. |
| 18150553 | Process for the preparation of oligonucleotides using modified oxidation protocol | Final Rejection | Hoffmann-La Roche Inc. |
| 18566013 | CHIMERIC NUCLEIC ACID OLIGOMER INCLUDING PHOSPHOROTHIOATE AND BORANOPHOSPHATE, AND METHOD FOR PRODUCING SAME | Final Rejection | TOKYO UNIVERSITY OF SCIENCE FOUNDATION |
| 18542500 | NUCLEOSIDE-5'-OLIGOPHOSPHATES HAVING A CATIONICALLY-MODIFIED NUCELOBASE | Non-Final OA | Roche Sequencing Solutions, Inc. |
| 18379047 | VIRAL INHIBITORS, THE SYNTHESIS THEREOF, AND INTERMEDIATES THERETO | Non-Final OA | Takeda Pharmaceutical Company Limited |
| 18717596 | COMBINATION OF A HIGH MOLECULAR WEIGHT CROSS-LINKED HYALURONIC ACID AND A LOW MOLECULAR WEIGHT NON-CROSS-LINKED HYALURONIC ACID | Non-Final OA | L V M H RECHERCHE |
| 18614126 | KIT FOR PREVENTING OR TREATING FILOVIRUS AND FLAVIVIRUS DISEASES | Final Rejection | HER MAJESTY THE QUEEN IN RIGHT OF CANADA AS REPRESENTED BY THE MINISTER OF HEALTH |
| 18565787 | PREVENTIVE AND THERAPEUTIC AGENT FOR URINARY TRACT INFECTION CONTAINING 1-DEOXYMANNOSE | Final Rejection | SUNUS CO., LTD. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy